Vemurafenib Recruiting Phase 1 Trials for Metastatic Melanoma, BRAF V600 Mutation Positive Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02608034A Study to Investigate the Effect of Itraconazole and Rifampin on Pharmacokinetics (PK) of Vemurafenib at Steady State